Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,624,000 | 1,029,400 | 478,000 | 1,198,500 | 1,024,992 |
| Depreciation Amortization | 105,400 | 70,000 | 36,400 | 145,500 | 110,960 |
| Income taxes - deferred | -33,500 | -15,500 | -6,400 | 318,800 | -108,242 |
| Accounts receivable | -228,600 | -64,900 | 30,400 | -362,700 | -359,829 |
| Other Working Capital | -447,600 | -204,800 | 32,600 | -926,500 | -711,707 |
| Other Operating Activity | 446,600 | 199,200 | 47,800 | 933,500 | 783,989 |
| Operating Cash Flow | $1,466,300 | $1,013,400 | $618,800 | $1,307,100 | $740,163 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -889,500 | -719,000 | -346,000 | -732,600 | -504,473 |
| PPE Investments | -297,600 | -191,400 | -79,400 | -272,600 | -164,963 |
| Other Investing Activity | -10,000 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-1,197,100 | $-910,400 | $-425,400 | $-1,005,200 | $-669,436 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 57,000 | 57,000 |
| Debt Repayment | N/A | N/A | N/A | -19,900 | -19,925 |
| Common Stock Issued | 87,400 | 34,100 | 13,400 | 240,200 | 226,892 |
| Common Stock Repurchased | -81,500 | -31,900 | 0 | -301,700 | -77,832 |
| Financing Cash Flow | $5,900 | $2,200 | $13,400 | $-24,400 | $186,135 |
| Beginning Cash Position | 825,200 | 825,200 | 825,200 | 547,700 | 547,703 |
| End Cash Position | 1,100,300 | 930,400 | 1,032,000 | 825,200 | 804,565 |
| Net Cash Flow | $275,100 | $105,200 | $206,800 | $277,500 | $256,862 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,466,300 | 1,013,400 | 618,800 | 1,307,100 | 740,163 |
| Capital Expenditure | -297,600 | -191,400 | -79,400 | -272,600 | -164,963 |
| Free Cash Flow | 1,168,700 | 822,000 | 539,400 | 1,034,500 | 575,200 |